SNMMI concerned about oncology coverage guidelines

William Doss | | Radiology Business | Nuclear Medicine

The Society of Nuclear Medicine and Molecular Imaging expressed their concern with an updated list of oncology coding recommendations released by eviCore, a benefits management company.

eviCore will no longer cover vluiciclovinem, choline or GA DOTATE for PET imaging, citing that the scans are "considered investigational and experimental for all indications for prostate cancer at this time." SNMMI will continue to follow the issue and is working with patient advocay groups to formulate a response.

Follow the link below to learn more about these updated coverage guidelines:

Updated eviCore Oncology Guidelines Cover Only FDG for PET Imaging

William Doss

As a Senior Writer for TriMed Media Group, Will covers radiology practice improvement, policy, and finance. He lives in Chicago and holds a bachelor’s degree in Life Science Communication and Global Health from the University of Wisconsin-Madison. He previously worked as a media specialist for the UW School of Medicine and Public Health. Outside of work you might see him at one of the many live music venues in Chicago or walking his dog Holly around Lakeview.

Related Content

Radiopharmaceutical firm Telix investing up to $171M to acquire portfolio of imaging agents
Lantheus expects sales of ‘blockbuster’ cancer imaging agent to surpass $1B in 2024
Global shortage of nuclear imaging isotopes may be over
Bracco Imaging radiopharmaceutical firm Blue Earth Therapeutics raises nearly $77M
GE HealthCare moves PET/CT scanner production to United States
FDA grants priority review for new brain cancer imaging agent

Around the web

Cardiovascular Business
Global shortage of nuclear imaging isotopes may be over

The nuclear imaging isotope shortage of molybdenum-99 may be over now that the sidelined reactor is restarting. ASNC's president says PET and new SPECT technologies helped cardiac imaging labs better weather the storm.

Cardiovascular Business
‘A huge win’: CMS significantly increases Medicare payments for cardiac CT

CMS has more than doubled the CCTA payment rate from $175 to $357.13. The move, expected to have a significant impact on the utilization of cardiac CT, received immediate praise from imaging specialists.

Cardiovascular Business
GE HealthCare moves PET/CT scanner production to United States

The all-in-one Omni Legend PET/CT scanner is now being manufactured in a new production facility in Waukesha, Wisconsin.

Design by Adaptive Theme
Trimed Popup
Trimed Popup